Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Small-airways deposition of dornase alfa in children with asthma and persistent airway obstruction.

Bakker EM, van der Wiel-Kooij EC, Müllinger B, Kroneberg P, Hop WC, Tiddens HA.

J Allergy Clin Immunol. 2013 Aug;132(2):482-5.e10. doi: 10.1016/j.jaci.2013.02.006. Epub 2013 Mar 28. No abstract available.

PMID:
23541323
[PubMed - indexed for MEDLINE]
2.

Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.

Bakker EM, Volpi S, Salonini E, Müllinger B, Kroneberg P, Bakker M, Hop WC, Assael BM, Tiddens HA.

Pediatr Pulmonol. 2014 Feb;49(2):154-61. doi: 10.1002/ppul.22800. Epub 2013 Jul 3.

PMID:
23913868
[PubMed - indexed for MEDLINE]
3.

Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group.

Geller DE, Eigen H, Fiel SB, Clark A, Lamarre AP, Johnson CA, Konstan MW.

Pediatr Pulmonol. 1998 Feb;25(2):83-7.

PMID:
9516090
[PubMed - indexed for MEDLINE]
4.

Lack of correlation between clinical patterns of asthma and airway obstruction.

Verini M, Rossi N, Dalfino T, Verrotti A, Di Gioacchino M, Chiarelli F.

Allergy Asthma Proc. 2001 Sep-Oct;22(5):297-302.

PMID:
11715220
[PubMed - indexed for MEDLINE]
5.

Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation.

Bakker EM, Volpi S, Salonini E, van der Wiel-Kooij EC, Sintnicolaas CJ, Hop WC, Assael BM, Merkus PJ, Tiddens HA.

Eur Respir J. 2011 Dec;38(6):1328-35. doi: 10.1183/09031936.00006211. Epub 2011 Jul 7.

PMID:
21737560
[PubMed - indexed for MEDLINE]
Free Article
6.

The effect of vagolytic drugs on airway obstruction in patients with bronchial asthma.

Firstater E, Mizrachi E, Topilsky M.

Ann Allergy. 1981 Jun;46(6):332-5.

PMID:
6454371
[PubMed - indexed for MEDLINE]
7.

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.

Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW; Pulmozyme Early Intervention Trial Study Group.

J Pediatr. 2001 Dec;139(6):813-20.

PMID:
11743506
[PubMed - indexed for MEDLINE]
8.

Ventilatory impairment in asthma: perceptions vs measurements.

Falliers CJ.

Chest. 1998 Feb;113(2):265-7. No abstract available.

PMID:
9498934
[PubMed - indexed for MEDLINE]
9.

Persistent peripheral airway obstruction in children with severe asthma.

Akhter J, Gaspar MM, Newcomb RW.

Ann Allergy. 1989 Jul;63(1):53-8.

PMID:
2742216
[PubMed - indexed for MEDLINE]
10.

Is maximum mid-expiratory flow rate sensitive to small airways obstruction?

Bake B.

Eur J Respir Dis. 1981 Jun;62(3):150-1. No abstract available.

PMID:
7308328
[PubMed - indexed for MEDLINE]
11.

Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma.

Hakala K, Stenius-Aarniala B, Sovijärvi A.

Chest. 2000 Nov;118(5):1315-21.

PMID:
11083680
[PubMed - indexed for MEDLINE]
12.

The use of recombinant human dornase alfa in CF.

Cox C.

Paediatr Nurs. 1995 Nov;7(9):29-31. Review. No abstract available.

PMID:
8705343
[PubMed - indexed for MEDLINE]
13.

Inhalation therapy for bronchial asthma: strategies and targets.

Magnussen H.

Curr Opin Pulm Med. 2003 Apr;9 Suppl 1:S3-7. Review.

PMID:
12974535
[PubMed - indexed for MEDLINE]
14.

[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].

Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M.

Arch Pediatr. 1998 Apr;5(4):371-7. French.

PMID:
9759155
[PubMed - indexed for MEDLINE]
15.

MMEF or FEV1 in estimating bronchial obstruction in asthmatic children.

Dalén G, Kjellman B.

Allergy. 1983 Apr;38(3):207-9.

PMID:
6846749
[PubMed - indexed for MEDLINE]
16.

Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.

McCoy K, Hamilton S, Johnson C.

Chest. 1996 Oct;110(4):889-95.

PMID:
8874241
[PubMed - indexed for MEDLINE]
17.

Persisting airway obstruction in asymptomatic children with asthma with normal peak expiratory flow rates.

Ferguson AC.

J Allergy Clin Immunol. 1988 Jul;82(1):19-22.

PMID:
3392366
[PubMed - indexed for MEDLINE]
18.

A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.

Shah PL, Conway S, Scott SF, Rainisio M, Wildman M, Stableforth D, Hodson ME.

Respiration. 2001;68(2):160-4.

PMID:
11287830
[PubMed - indexed for MEDLINE]
Free Article
19.

[Current therapeutic agents: dornase alfa].

Baran D, Sternon J.

Rev Med Brux. 1997 Feb;18(1):37-40. Review. French.

PMID:
9132917
[PubMed - indexed for MEDLINE]
20.

Early treatment with dornase alfa in cystic fibrosis: what are the issues?

Bush A.

Pediatr Pulmonol. 1998 Feb;25(2):79-82. No abstract available.

PMID:
9516089
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk